FindTrial
Sign In

Comparison between once-per-cycle peg-Filgrastim and daily injection r-Hu-G-CSF in chemotherapy-induced neutropenia treatment and peripheral blood progenitor cells mobilization in childhood.

Comparison between once-per-cycle peg-Filgrastim and daily injection r-Hu-G-CSF in chemotherapy-induced neutropenia treatment and peripheral blood progenitor cells mobilization in childhood.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-002136-10-IT
Enrollment
Unknown
Registered
2005-06-28
Start date
2005-07-08
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy-induced neutropenia treatment peripheral blood progenitor cells mobilization MedDRA version: 6.1 Level: PT Classification code 10029354

Interventions

Product Name: NA Product Code: NA Pharmaceutical Form: Solution for injection INN or Proposed INN: Pegfilgrastim Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 6-

Sponsors

ISTITUTO GIANNINA GASLINI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026